US court OKs use of drug implicated in botched executions

Image
AP Washington
Last Updated : Jun 29 2015 | 9:42 PM IST
The US Supreme Court today upheld the use of a controversial drug that has been implicated in several botched executions.
Meanwhile, two of the justices said for first time that death penalty itself probably is unconstitutional.
The justices voted 5-4 in a case from the state of Oklahoma that the sedative midazolam can be used in executions without violating a constitutional prohibition on cruel and unusual punishment.
The drug used in executions in Arizona, Ohio and Oklahoma in 2014 took longer than usual and raised concerns that it did not perform its intended task of putting inmates into a coma-like sleep.
In Oklahoma, state officials tried to halt the lethal injection after the inmate writhed on the gurney and moaned. He died 43 minutes after the process began.
Executions have been on hold in Ohio since a troubling 26-minute execution in 2014 during which a prisoner getting a first-ever two-drug combo repeatedly gasped and snorted.
Last year, Arizona officials were cleared of any wrongdoing in an execution that lasted nearly two hours, but they nevertheless changed the drugs they use to put inmates to death.
Justice Samuel Alito said for a conservative majority Monday that arguments the drug could not be used effectively as a sedative in executions is speculative.
In dissent, Justice Sonia Sotomayor said, "Under the court's new rule, it would not matter whether the state intended to use midazolam, or instead to have petitioners drawn and quartered, slowly tortured to death, or actually burned at the stake."
Alito responded, saying "the dissent's resort to this outlandish rhetoric reveals the weakness of its legal arguments."
In a separate dissent, Justice Stephen Breyer said the time has come for the court to debate whether the death penalty itself is constitutional. Another justice joined that opinion.
The Supreme Court's involvement in the case began in January with an unusually public disagreement among the justices over executions.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 29 2015 | 9:42 PM IST

Next Story